Allarity Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), Unrealized
Allarity Therapeutics, Inc. (ALLR) reported Foreign Currency Transaction Gain (Loss), Unrealized of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-08-14
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-12-31 was -$1.25M, a 1178.45% decline year-over-year.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2025 was -$1.24M, a 1082.54% decline from fiscal 2024.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2024 was $126.00K, a 29.61% decline from fiscal 2023.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2023 was $179.00K.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2022 was -$450.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month as first filed | Foreign Currency Transaction Gain (Loss), Unrealized 12 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | -$1.25M derived: sum of 3 quarters · filed 2026-08-14 | -$1.25M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | -$1.25M derived: sum of 2 quarters · filed 2026-05-15 | -$1.25M derived: sum of 3 quarters · filed 2026-05-15 | -$1.25M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$1.25M derived: sum of 2 quarters · filed 2026-03-30 | -$1.25M derived: sum of 3 quarters · filed 2026-08-14 | -$1.24M 10-K · filed 2026-03-30 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.00K derived: sum of 2 quarters · filed 2026-08-14 | $13.00K 10-Q · filed 2025-11-14 | $129.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $13.00K 10-Q · filed 2026-08-14 | $129.00K derived: sum of 3 quarters · filed 2026-08-14 | $162.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $12.00K 10-Q · filed 2026-05-15 | $128.00K derived: sum of 2 quarters · filed 2026-05-15 | $161.00K derived: sum of 3 quarters · filed 2026-05-15 | $62.00K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $149.00K derived: sum of 2 quarters · filed 2026-03-30 | $50.00K derived: sum of 3 quarters · filed 2026-03-30 | $126.00K 10-K · filed 2026-03-30 | ||
| 2024-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$66.00K derived: sum of 2 quarters · filed 2025-11-14 | $10.00K 10-Q · filed 2025-11-14 | $277.00K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | -$99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | -$23.00K 10-Q · filed 2025-08-15 | $244.00K derived: sum of 3 quarters · filed 2025-08-15 | $97.00K derived: sum of 4 quarters · filed 2025-08-15 | ||
| 2024-03-31 | $76.00K 10-Q · filed 2025-05-09 | $343.00K derived: sum of 2 quarters · filed 2025-05-09 | $196.00K derived: sum of 3 quarters · filed 2025-05-09 | $168.00K derived: sum of 4 quarters · filed 2025-05-09 | ||
| 2023-12-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $120.00K derived: sum of 2 quarters · filed 2025-03-31 | $92.00K derived: sum of 3 quarters · filed 2025-03-31 | $179.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$175.00K derived: sum of 2 quarters · filed 2024-11-14 | -$88.00K 10-Q · filed 2024-11-14 | -$393.00K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $59.00K 10-Q · filed 2024-08-05 | -$246.00K derived: sum of 3 quarters · filed 2024-08-05 | $147.00K derived: sum of 4 quarters · filed 2024-08-05 | ||
| 2023-03-31 | $87.00K 10-Q · filed 2024-05-14 | -$218.00K derived: sum of 2 quarters · filed 2024-05-14 | $175.00K derived: sum of 3 quarters · filed 2024-05-14 | -$108.00K derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | -$305.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $88.00K derived: sum of 2 quarters · filed 2024-03-08 | -$195.00K derived: sum of 3 quarters · filed 2024-03-08 | -$450.00K 10-K · filed 2024-03-08 | ||
| 2022-09-30 | $393.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $110.00K derived: sum of 2 quarters · filed 2023-11-14 | -$145.00K 10-Q · filed 2023-11-14 | -$169.00K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$538.00K 10-Q · filed 2023-08-14 | -$562.00K derived: sum of 3 quarters · filed 2023-08-14 | -$553.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$255.00K 10-Q · filed 2023-05-11 | -$279.00K derived: sum of 2 quarters · filed 2023-05-11 | -$270.00K derived: sum of 3 quarters · filed 2023-05-11 | -$311.00K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$15.00K derived: sum of 2 quarters · filed 2023-03-13 | -$56.00K derived: sum of 3 quarters · filed 2023-03-13 | -$95.00K 10-K · filed 2023-03-13 | $74.00K 10-K · filed 2022-05-17 | |
| 2021-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$32.00K derived: sum of 2 quarters · filed 2022-11-14 | -$71.00K 10-Q · filed 2022-11-14 | -$29.00K 10-Q · filed 2021-11-23 | -$264.00K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-07 | -$80.00K 10-Q · filed 2022-10-07 | -$273.00K derived: sum of 3 quarters · filed 2022-10-07 | |||
| 2021-03-31 | -$39.00K 10-Q · filed 2022-05-27 | -$232.00K derived: sum of 2 quarters · filed 2022-05-27 | ||||
| 2020-12-31 | -$193.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-05-17 | $68.00K 10-K · filed 2022-05-17 | ||||
| 2020-09-30 | $261.00K 10-Q/A · filed 2022-05-17 | $118.00K 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |